Sleep duration and cardiometabolic risk among Chinese school-aged children: Do adipokines play a mediating role?

Sleep

Volumn 40, Issue 5, 2017, Pages

  Li, Lujiao ^a   Fu, Junling ^a   Yu, Xin Ting ^a   Li, Ge ^a   Xu, Lu ^a   Yin, Jinghua ^a   Cheng, Hong ^b   Hou, Dongqing ^b   Zhao, Xiaoyuan ^b   Gao, Shan ^c   Li, Wenhui ^a   Li, Changhong ^d   Grant, Struan F A ^d,e   Li, Ming ^a,d   Li, Mingyao ^f   Xiao, Yi ^a   Mi, Jie ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL INSTITUTE OF PEDIATRICS   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adipokines; Cardiometabolic risk factors; Children; Sleep duration

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; FIBROBLAST GROWTH FACTOR; GLUCOSE BLOOD LEVEL; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; RETN PROTEIN, HUMAN;

ARTICLE; BODY MASS; BREAST DEVELOPMENT; CARDIOMETABOLIC RISK; CHILD; CHINESE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; SLEEP; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASE; CHINA; ETHNOLOGY; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY; RISK FACTOR; SECRETION (PROCESS); TIME FACTOR;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CHINA; CHOLESTEROL, HDL; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; RESISTIN; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; SLEEP; TIME FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 85019727778     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/zsx042     Document Type: Article

References (44)

1. Lobstein T, Jackson-Leach R, Moodie ML, et al. Child and adolescent obesity: Part of a bigger picture. Lancet. 2015; 385(9986): 2510-2520.
2. Matricciani LA, Olds TS, Blunden S, Rigney G, Williams MT. Never enough sleep: A brief history of sleep recommendations for children. Pediatrics. 2012; 129(3): 548-556.
3. Fatima Y, Doi SA, Mamun AA. Longitudinal impact of sleep on overweight and obesity in children and adolescents: A systematic review and bias-adjusted meta-analysis. Obes Rev. 2015; 16(2): 137-149.
4. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: A systematic review and meta-analysis of prospective studies. Eur Heart J. 2011; 32(12): 1484-1492.
5. Killick R, Banks S, Liu PY. Implications of sleep restriction and recovery on metabolic outcomes. J Clin Endocrinol Metab. 2012; 97(11): 3876-3890.
6. Nakamura K, Fuster JJ, Walsh K. Adipokines: A link between obesity and cardiovascular disease. J Cardiol. 2014; 63(4): 250-259.
7. Balagopal PB, de Ferranti SD, Cook S, et al.; American Heart Association Committee on Atherosclerosis Hypertension and Obesity in Youth of the Council on Cardiovascular Disease in the Young; Council on Nutrition, Physical Activity and Metabolism; Council on Epidemiology and Prevention. Nontraditional risk factors and biomarkers for cardiovascular disease: Mechanistic, research, clinical considerations for youth: A scientific statement from the American Heart Association. Circulation. 2011; 123(23): 2749-2769.
8. Hayes AL, Xu F, Babineau D, Patel SR. Sleep duration and circulating adipokine levels. Sleep. 2011; 34(2): 147-152.
9. St-Onge MP. The role of sleep duration in the regulation of energy balance: Effects on energy intakes and expenditure. J Clin Sleep Med. 2013; 9(1): 73-80.
10. Boeke CE, Storfer-Isser A, Redline S, Taveras EM. Childhood sleep duration and quality in relation to leptin concentration in two cohort studies. Sleep. 2014; 37(3): 613-620.
11. Hitze B, Bosy-Westphal A, Bielfeldt F, et al. Determinants and impact of sleep duration in children and adolescents: Data of the Kiel Obesity Prevention Study. Eur J Clin Nutr. 2009; 63(6): 739-746.
12. Martinez-Gomez D, Eisenmann JC, Gomez-Martinez S, et al.; AFINOS Study Group. Sleep duration and emerging cardiometabolic risk markers in adolescents. The AFINOS study. Sleep Med. 2011; 12(10): 997-1002.
13. Simpson NS, Banks S, Arroyo S, Dinges DF. Effects of sleep restriction on adiponectin levels in healthy men and women. Physiol Behav. 2010; 101(5): 693-698.
14. Al-Disi D, Al-Daghri N, Khanam L, et al. Subjective sleep duration and quality influence diet composition and circulating adipocytokines and ghrelin levels in teen-age girls. Endocr J. 2010; 57(10): 915-923.
15. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond). 2009; 33(4): 424-439.
16. Group of China Obesity Task Force. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(2): 97-102.
17. Li M, Wu C, Song A, et al. Development and preliminary application of enzyme-linked immunosorbent assay for human net insulin in serum. Chinese J Endocrinol Metab. 1997; 13(4): 214-217.
18. Li M, Yin JH, Zhang K, Wu CY. [A highly sensitive enzyme-linked immunosorbent assay for measurement of leptin secretion in human adipocytes]. Zhonghua Yi Xue Za Zhi. 2008; 88(46): 3293-3297.
19. Li Q, Lu Y, Sun L, et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism. 2012; 61(12): 1803-1808.
20. Xu L, Ping F, Yin J, et al. Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, inflammation in gestational diabetes mellitus. PLoS One. 2013; 8(12): E81615.
21. Li L, Yin J, Cheng H, et al. Identification of genetic and environmental factors predicting metabolically healthy obesity in children: Data from the BCAMS study. J Clin Endocrinol Metab. 2016; 101(4): 1816-1825.
22. Garaulet M, Ortega FB, Ruiz JR, et al. Short sleep duration is associated with increased obesity markers in European adolescents: Effect of physical activity and dietary habits. The HELENA study. Int J Obes (Lond). 2011; 35(10): 1308-1317.
23. Azadbakht L, Kelishadi R, Khodarahmi M, et al. The association of sleep duration and cardiometabolic risk factors in a national sample of children and adolescents: The CASPIAN III study. Nutrition. 2013; 29(9): 1133-1141.
24. Chen X, Beydoun MA, Wang Y. Is sleep duration associated with childhood obesity A systematic review and meta-analysis. Obesity (Silver Spring). 2008; 16(2): 265-274.
25. Guidolin M, Gradisar M. Is shortened sleep duration a risk factor for overweight and obesity during adolescence A review of the empirical literature. Sleep Med. 2012; 13(7): 779-786.
26. Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation's sleep time duration recommendations: Methodology and results summary. Sleep Health. 2015; 1(1): 40-43.
27. Li S, Zhu S, Jin X, et al. Risk factors associated with short sleep duration among Chinese school-aged children. Sleep Med. 2010; 11(9): 907-916.
28. Matthews KA, Pantesco EJ. Sleep characteristics and cardiovascular risk in children and adolescents: An enumerative review. Sleep Med. 2016; 18: 36-49.
29. Androutsos O, Moschonis G, Mavrogianni C, et al. Identification of lifestyle patterns, including sleep deprivation, associated with insulin resistance in children: The Healthy Growth Study. Eur J Clin Nutr. 2014; 68(3): 344-349.
30. Tian Z, Ye T, Zhang X, et al. Sleep duration and hyperglycemia among obese and nonobese children aged 3 to 6 years. Arch Pediatr Adolesc Med. 2010; 164(1): 46-52.
31. Cespedes EM, Rifas-Shiman SL, Redline S, Gillman MW, Penã MM, Taveras EM. Longitudinal associations of sleep curtailment with metabolic risk in mid-childhood. Obesity (Silver Spring). 2014; 22(12): 2586-2592.
32. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, increased body mass index. PLoS Med. 2004; 1(3): E62.
33. Chaput JP, Després JP, Bouchard C, Tremblay A. Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring). 2007; 15(1): 253-261.
34. Pejovic S, Vgontzas AN, Basta M, et al. Leptin and hunger levels in young healthy adults after one night of sleep loss. J Sleep Res. 2010; 19(4): 552-558.
35. Simpson NS, Banks S, Dinges DF. Sleep restriction is associated with increased morning plasma leptin concentrations, especially in women. Biol Res Nurs. 2010; 12(1): 47-53.
36. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr. 2009; 89(1): 126-133.
37. Hart CN, Carskadon MA, Considine RV, et al. Changes in children's sleep duration on food intake, weight, leptin. Pediatrics. 2013; 132(6): E1473-e1480.
38. Saínz N, Barrenetxe J, Moreno-Aliaga MJ, Martínez JA. Leptin resistance and diet-induced obesity: Central and peripheral actions of leptin. Metabolism. 2015; 64(1): 35-46.
39. Xu L, Li M, Yin J, et al. Change of body composition and adipokines and their relationship with insulin resistance across pubertal development in obese and nonobese Chinese children: The BCAMS study. Int J Endocrinol. 2012; 2012(6): 389108
40. 389108. 40. Parker-Duffen JL, Walsh K. Cardiometabolic effects of adiponectin. Best Pract Res Clin Endocrinol Metab. 2014; 28(1): 81-91.
41. Sarruf DA, Thaler JP, Morton GJ, et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes. 2010; 59(7): 1817-1824.
42. Kharitonenkov A, Adams AC. Inventing new medicines: The FGF21 story. Mol Metab. 2014; 3(3): 221-229.
43. Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, response to pioglitazone. J Clin Endocrinol Metab. 2007; 92(7): 2590-2597.
44. Jung UJ, Choi MS. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15(4): 6184-6223.